Hyliion is trading 5.01% lower at $3.57, with no confirmed company-specific catalyst for the decline. - A shareholder alert issued October 13 highlighted the October 27 deadline in a securities-fraud class action alleging misleading statements about the company’s operations, growth prospects, and financial stability. - The alert does not establish that the lawsuit news caused the decline. The broader market was nearly flat, and available evidence points to no clear market-wide explanation.